Lv658
2148 积分 2024-09-24 加入
Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
29天前
已完结
An Overview of CDK Enzyme Inhibitors in Cancer Therapy
1个月前
已完结
Potential Target of CDK6 Signaling Pathway for Cancer Treatment
1个月前
已完结
An update on the development on tubulin inhibitors for the treatment of solid tumors
1个月前
已完结
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
1个月前
已完结
Urinary metabolites of busulfan in the rat
5个月前
已完结
Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
5个月前
已完结
On the Diversity of Oxidative Bioactivation Reactions on Nitrogen- Containing Xenobiotics
6个月前
已完结
Discovery of Unprecedented Human Stercobilin Conjugates
6个月前
已完结
Prediction of Drug–Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic Model
6个月前
已完结
皖公网安备34019202002308
